Table 3. Spearman Correlations between Clinical Characteristics and mRNA Expression Levels of the Study Subjects.
| BTRC |
FBXL4 |
UBE2D2 |
ASB1 |
|||||
|---|---|---|---|---|---|---|---|---|
| parameters | coefficient | P | coefficient | P | coefficient | P | coefficient | P |
| age (years) | –0.137 | 0.052 | –0.112 | 0.118 | –0.068 | 0.335 | –0.089 | 0.229 |
| gender | 0.006 | 0.928 | 0.106 | 0.135 | –0.038 | 0.584 | –0.043 | 0.556 |
| BMI (kg/m2) | 0.027 | 0.722 | 0.061 | 0.429 | –0.076 | 0.314 | 0.070 | 0.377 |
| SBP (mmHg) | 0.094 | 0.182 | 0.000 | 0.996 | 0.032 | 0.653 | 0.137 | 0.063 |
| DBP (mmHg) | 0.166 | 0.018 | 0.069 | 0.338 | 0.010 | 0.893 | 0.220 | 0.003 |
| CRP (mg/L) | 0.044 | 0.531 | 0.011 | 0.874 | 0.039 | 0.585 | 0.023 | 0.758 |
| total cholesterol (mg/dL) | 0.023 | 0.747 | –0.002 | 0.981 | 0.021 | 0.765 | –0.078 | 0.292 |
| TG (mg/dL) | –0.059 | 0.404 | –0.099 | 0.172 | 0.057 | 0.428 | 0.121 | 0.102 |
| HDL-C (mg/dL) | 0.125 | 0.078 | 0.142 | 0.049 | –0.006 | 0.931 | –0.034 | 0.647 |
| LDL-C (mg/dL) | 0.033 | 0.643 | 0.021 | 0.776 | 0.022 | 0.757 | –0.085 | 0.253 |
| GLU (mg/dL) | –0.042 | 0.552 | –0.150 | 0.037 | 0.092 | 0.198 | –0.125 | 0.091 |
| Lp (a) (mg/L) | –0.098 | 0.168 | –0.089 | 0.218 | 0.038 | 0.598 | –0.129 | 0.081 |
| Gensini score | –0.323 | <0.001 | –0.374 | <0.001 | 0.285 | <0.001 | –0.308 | <0.001 |
| BTRC | NA | NA | 0.386 | <0.001 | 0.041 | 0.560 | 0.263 | <0.001 |
| FBXL4 | 0.386 | <0.001 | NA | NA | –0.003 | 0.969 | 0.227 | <0.001 |
| UBE2D2 | 0.041 | 0.560 | –0.003 | 0.969 | NA | NA | –0.120 | 0.101 |
| ASB1 | 0.027 | 0.710 | 0.113 | 0.126 | –0.058 | 0.428 | NA | NA |